EGF and osteoarthritis: Inclusion of rebamipide in the complex 1-month treatment of Helicobacter pylori-associated gastroduodenopathies caused by nonsteroidal anti-inflammatory drugs in patients with osteoarthritis showed a significant decrease in tumor necrosis factor-α and compensatory growth of epidermal growth factor reparative processes in the mucous membrane of the stomach and duodenum.